Ayurcann

Toll Processing & White Label Solutions for Licensed Producers

This AyurCann profile is part of a paid investor education campaign.*

Overview

In an industry that was previously reliant on grower companies, more fully integrated companies delivering multiple verticals in cannabis processing and production offer an unparalleled investment opportunity that stands out from the rest.

Ayurcann (CSE:AYUR) is a leading B2B post-harvest solution and provider focused on providing scalable custom processes and pharma-grade products to the medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by delivering best-in-class, proprietary services, including ethanol extraction, formulation, product development and custom manufacturing.

The company offers a two-tier business model of services and production. The manufacturing vertical offers three production divisions specializing in expert cannabis-based extraction and refinement, high-quality bulk oil sales and white label manufacturing. Ayurcann currently extracting approximately 1,500 kilograms a week of product and has the capacity to process up to 200,000 kilograms of dry cannabis annually.

Additionally, its proprietary Ayurcann Marketplace offers a premium selection of cannabis and hemp products, including tinctures, vapes and topicals for personalized care.

The company operates out of Pickering, Ontario, allowing Ayurcann to leverage easy access to licensed producers and other cannabis participants in the region. It also holds Processing and Research Licences issued by Health Canada.

Ayurcann’s management team consists of innovators in the cannabis and corporate space that bring together years of experience in business development, finance, post-harvest production and quality control. This leadership and their vested interest in the success of

Ayurcann’s Company Highlights

  • Ayurcann is a premier post-harvest cannabis solutions company focused on providing and manufacturing unique development processes and high-quality products for patient and adult use in Canada.
  • The company aims to be a market leader and supportive partner within the cannabis extraction business. It has created turn-key-post harvest outsourcing for licensed cannabis producers, using a strategic end-to-end model.
  • The company’s Ayurcann Solutions offers premium services across various cannabis production verticals. This portfolio includes expert cannabis-based extraction and refinement, high-quality bulk oil sales and white label manufacturing.
  • Ayurcann also operates the Ayurcann Marketplace, specializing in safe and well-engineered medicinal cannabis concentrate products for personalized and patient care.  

Ayurcann’s Key Solutions

Production Division

Ayuracann’s production division, offers full end-to-end outsourcing services, including proprietary product research & development, cannabis extraction & refinement and final production formulation & fulfillment. The company leverages experience, expertise and a robust network to assist clients across Canada and the world.

Ayurcann provides multiple verticals in cannabis production. These premier services include well-engineered extraction and refinement, high-quality bulk oil sales for manufacturers and brands and white label manufacturing for product development to commercialization.

Medicinal Cannabis Marketplace

The Ayurcann Marketplace offers a personalized level of care through its high-quality, safe and consistent medicinal cannabis tailored to patient needs. This robust selection of premier cannabis products includes tinctures, vapes and topicals.

The company leverages an impressive library of terpenes and utilizes flexible production and concentration processes to address unique customer needs.

Ayurcann’s Management Team

Igal Sudman — CEO & Co-Founder, Director

Igal Sudman is a business development specialist who brings over 20 years of experience in various industries, from real estate development to technology and cannabis. Sudman understands the objectives and requirements needed to scale companies from seed to exit, having founded and developed businesses featured on the Canadian Profit 50.

Roman Buzaker — President, COO & Co-Founder, Director

Roman Buzaker is a corporate strategist with a specialty in management and operational engineering. He has experience in industries such as logistics, digital marketing and business consulting. Buzaker managed the expansion and the development of various online and brick-and-mortar companies from single-location operations to multi-locational franchises nationwide.

Jaspreet Bhatia — Quality Control Manager

Jaspreet Bhatia is a quality control manager with a Ph.D. Degree in Chemistry. She has over five years of quality control experience and in-depth knowledge of GMP, GLP, Cannabis regulations and quality guidelines. She possesses extensive knowledge and expertise in technical writing, product development and product release

Raj Virk — Quality & Compliance Manager

Raj Virk is a quality system expert with over 18 years of experience in the pharmaceutical industry. Virk is highly skilled and experienced in GMP, GPP, quality investigations, deviation reports, technical writing and quality audits.

He holds a Master’s Degree in science along with a Postgraduate Diploma in Pharmaceutical Quality Assurance.

Aaron Meckler — CFO

Aaron Meckler is a seasoned corporate finance professional with over eight years of experience in public and private equity, covering real estate, growth-stage ventures, public listings and M&A transactions. He has acted in a CFO capacity for public and private companies and currently sits on the board of directors for two reporting issuers, Stralak Resources and Brandenburg Energy.

Alison Gordon — Director

Alison Gordon has worked in all verticals of this emerging market. As the founder of 48North Cannabis Corp, Gordon was the first female CEO of a public cannabis company. Gordon developed strategies for patient acquisition, brand awareness, investor relations, customer service, physician outreach, and has traveled all over North America, applying her vast marketing experience to evaluating investment and acquisition.

Gordon’s competitive advantage is her hands-on experience in production, distribution and retail across several vastly different markets throughout the US and Canada.

David Hackett — Director

David Hackett brings more than 20 years of financial and management leadership. He has overseen the growth of several start-up companies, including dealing with operations, technology, regulatory reporting, corporate governance, public financing and M&A activity.

Hackett is a CPA and CA and holds an MBA from the Richard Ivey School of Business at the Western University.

Maor Shayit — Director

Maor Shayit is a seasoned and ambitious operation & marketing professional with more than 15 years of experience driving national, sales and P&L growth across a wide range of industries, including retail, telecommunications and cannabis.

Shayit has successfully built and improved operations and marketing departments for the last three years for an emerging Ontario-based licensed producer as a COO.


*Disclaimer: This profile is sponsored by Ayurcann (CSE:AYUR). This profile provides information which was sourced by the Investing News Network (INN) and approved by  Ayurcann in order to help investors learn more about the company.  Ayurcann is a client of INN. The company’s campaign fees pay for INN to create and update this profile.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with  Ayurcann and seek advice from a qualified investment advisor.